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The risk factors and spread of multidrug-resistant
Acinetobacter baumannii in intubated patients in a
medical intensive care unit
Aim: Acinetobacter baumannii is one of the most common causes of ventilator-associated pneumonia
in intensive care units. The aim of this study was to determine the risk factors for colonization in the
respiratory tract and infection with A. baumannii in a medical intensive care unit (MICU), and to
examine the genetic link between strains and the spread of isolates.
Materials and methods: This study was conducted prospectively between 1 December 2004 and 31
January 2006 in the MICU. Patients (> 16 years old) admitted to the MICU that were mechanically
ventilated and/or intubated were enrolled in the study.
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Results: Ninety-eight patients were evaluated for A. baumannii colonization during or at the end of
their intubation; 44 (45%) of these patients were colonized by A. baumannii. The length of intubation
(OR: 1.032, P = 0.014) and diabetes mellitus (OR: 4.140, P = 0.008) were the major risk factors for
colonization of the respiratory tract by A. baumannii. During the study period A. baumannii infection
developed in 35 (80%) of the 44 colonized patients. The important risk factors for A. baumannii
infection were colonization (OR: 3.962, P = 0.006) and tracheostomy (OR: 4.857, P = 0.001).
Genotyping analysis was performed for 59 isolates. Overall, 3 clones (clone A, B, and C) were
identified in patients; 88% were clone A (52 isolates), 7% were clone B (4 isolates), and 5% were clone
C (3 isolates).
Conclusion: Length of intubation and diabetes mellitus were significant risk factors for A. baumannii
colonization in intubated patients. Moreover, colonization and tracheostomy predisposed patients to
infection. Additionally, this study documented the spread of multi-drug resistant A. baumannii in
intubated patients in an MICU with limited resources.
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Bir dahiliye yoğun bakım ünitesinde entübe hastalarda pek çok ilaca
dirençli Acinetobacter baumannii için risk faktörleri ve yayılımı
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Amaç: Acinetobacter baumannii yoğun bakım ünitelerinde ventilatör ilişkili pnömoninin önemli
etkenlerinden birini oluşturmaktadır. Kolonize hastalar çevre kontaminasyonu ve
mikroorganizmanın hastadan hastaya yayılımında önemli kaynaktırlar. Bu çalışmanın amacı, bir
dahiliye yoğun bakım ünitesinde (DYBÜ) A. baumannii ile solunum yollarının kolonizasyonu ve
enfeksiyonu için risk faktörlerinin belirlenmesi ve izolatların yayılımının gösterilmesi için suşların
genetik yakınlığının araştırılmasıdır.
Yöntem ve gereçler: Bu çalışma 1 Aralık 2004 ve 31 Ocak 2006 tarihleri arasında DYBÜ’sinde
prospektif olarak yapıldı. DYBÜ’sine yatırılan ve mekanik ventilasyona bağlanan ve/veya entübe
edilen hastalar (> 16 yaş) çalışmaya alındı. Bu hastaların endotrakeal aspiratları A. baumannii
kolonizasyonu için entübasyonun başında (ilk 48 saat içinde), birinci haftanın sonunda ve
endotrakeal tüpün çekilmesi sırasında araştırıldı. Her hasta kolonizasyon ve enfeksiyon için risk
faktörleri açısından değerlendirildi.
Bulgular: Doksan sekiz hasta A. baumannii kolonizasyonu için entübasyon süresince veya
entübasyonun sonunda değerlendirildi ve bu hastaların 44 (% 45)’ünde A. baumannii kolonizasyonu
tespit edildi. Entübasyon süresi (OR: 1,032, P = 0,014) ve diyabetes mellitus (OR: 4,140, P = 0,008)
solunum yollarının A. baumannii ile kolonizasyonu için önemli risk faktörleri olarak bulundu.
Çalışma dönemi boyunca, 44 kolonize hastanın 35 (% 80)’inde A. baumannii enfeksiyonu gelişti.

761

ALP, E et al.

Acinetobacter baumannii dissemination in an intensive care unit

Turk J Med Sci

Enfeksiyon gelişimi için major risk faktörleri A. baumannii kolonizasyonu (OR: 3,962, P = 0,006) ve
trakeostomi (OR: 4,857, P = 0,001) idi. Elli dokuz izolatın genotipik analizi yapıldı. Hastalarda toplam
üç klon (klon A, B, C) tespit edildi, ancak bunların % 88’i klon A’ya (52 izolat), % 7’si klon B’ye (dört
izolat) ve % 5’i klon C’ye (üç izolat) aitti.
Sonuç: Entübasyon süresi ve diyabetes mellitus entübe hastalarda A. baumannii kolonizasyonu için
önemli risk faktörleridir. Ayrıca, kolonizasyon ve trakeostomi enfeksiyon gelişimi için predispozan
olarak bulundu. Aynı zamanda bu çalışma kısıtlı kaynakları olan bir yoğun bakım ünitesinde entübe
hastalarda pek çok ilaca dirençli A. baumannii’nin yayılımını göstermektedir.
Anahtar sözcükler: Acinetobacter, yoğun bakım ünitesi, kolonizasyon, enfeksiyon kontrolü

Introduction
In recent years Acinetobacter baumannii has
become the leading cause of ventilator-associated
pneumonia (VAP) (1-3). The rapid development of
resistance to most antibiotics has emerged as an
important variable influencing mortality in patients
with A. baumannii VAP. Moreover, A. baumannii has
the capacity to survive on most environmental
surfaces for long periods of time, which promotes
environment-to-patient spread of the microorganism,
especially by healthcare workers (HCWs) (4,5). Many
outbreaks have been reported to be due to
contamination of surfaces and devices (4), and these
outbreaks were controlled by efficient environmental
cleaning and appropriate hand and device disinfection
(6-9). Additionally, colonization in patients plays an
important role in infection and spread of the
microorganism to other patients.
Erciyes University Hospital (Kayseri, Turkey) is a
1300-bed tertiary-referral teaching hospital with 10
adult intensive care units (ICUs) (103-bed capacity
and 27,947 patient admissions annually). Despite
efforts to control infection, nosocomial infection rates
remain high (20/1000 patient days) in our ICUs.
Moreover, VAP ratios are high (26.6/1000 ventilator
days) and 69% of these infections are due to
multidrug-resistant gram-negative pathogens (2006
hospital surveillance report). A. baumannii is an
etiological agent in 35% of VAP cases with excess
morbidity and mortality (10), and isolates are usually
multidrug resistant (11). This can be due to intubated
ICU patients that are colonized and easily develop
pneumonia after colonization. In addition, crosstransmission can occur from colonized/infected
patients to other patients because of inadequate
infrastructure (12). The present study aimed to
762

determine the risk factors for colonization of the
respiratory tract and infection with A. baumannii in
our medical ICU (MICU) and to examine the clonal
relatedness of the strains in order to show the
dissemination of isolates.
Methods
MICU design and infection control measures
The MICU has 9 beds and approximately 750
patients are admitted each year. Patient-based
surveillance is performed actively and daily by
infection control nurses. Infection control doctors
visit the MICU twice each week and there are posters
about infection control measures and hand hygiene
on the walls. Additionally, routine infection control
education programs for all health-care personnel are
offered twice a year. Standard infection control
measures are used for all patients. As there is no
isolation room for colonized patients, HCWs try to
use other contact measures (hand hygiene, gown,
glove, etc.) with patients colonized or infected with
multidrug-resistant organisms. The between-bed
space in the MICU is only 1-1.5 m and there is an
insufficient number of nurses (the 24-h nurse-topatient ratio is 0.7). There are 3 washbasins for 9 beds
and alcohol-based products are located at the bedside
of each patient.
Patients
This study was conducted prospectively between
1 December 2004 and 31 January 2006 in the MICU.
Patients (> 16 years old) admitted to the MICU that
were mechanically ventilated and/or intubated were
enrolled in the study. Endotracheal aspirate collected
from these patients was screened for A. baumannii at
the beginning of intubation (within the first 48 h), at
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the end of the first week, and at the time of withdrawal
of the endotracheal tube. Patients intubated for less
than 48 h were not included in the study and the data
on patients colonized or infected with A. baumannii at
ICU admission were not evaluated for the risk factors.
Patient data collected for evaluating risk factors
included age, sex, APACHE II score, SOFA score,
underlying diseases (diabetes mellitus, hypertension,
coronary artery disease, asthma, chronic obstructive
lung disease, chronic renal failure, chronic heart
failure, cerebrovascular disease, cirrhosis, neoplastic
disease, trauma), length of stay (LOS) in hospital
before MICU admission, LOS in MICU, previous
antibiotic administration, length of antibiotic therapy
before colonization, use of catheterization (peripheral,
central venous, arterial, urinary) or nasogastric tube,
total parenteral nutrition, tracheostomy, prostheses,
surgery, open wounds, and decubitus ulcer.
This study was approved by the Erciyes University
Ethics Committee (date: 04.05.2004; number: 132).
Microbiological studies
Organism identification
A. baumannii was preliminarily identified by the
bacteriology laboratory of Erciyes University Hospital.
Quantitative endotracheal aspirate cultures were
performed for all patients. Lactose- and oxidasenegative isolates were subcultured and A. baumannii
was identified using a Phoenix 100 system (Becton
Dickinson, USA). Isolates were stored at −80 °C until
studied.
Molecular typing
electrophoresis (PFGE)

by

pulsed-field

gel

Strains isolated from colonized and infected
patients were evaluated for genetic relatedness.
Genotyping analysis was performed by pulsed-field
gel electrophoresis (PFGE) at the clinical
microbiology laboratory of Yeditepe University,
İstanbul, Turkey.
Pulsed-Field Gel Electrophoresis
Acinetobacter DNA embedded in agarose blocks
was prepared, as described by Seifert et al. (13);
restriction endonuclease ApaI (Promega, Madison,
WI, USA) was used for digestion. The DNA
macrorestriction fragments were separated in 1.1%
agarose gel (Genaxis, Spechbach, Germany) by PFGE
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using CHEF Mapper (Bio Rad Laboratories CA,
USA). l-Ladder (Sigma, Deisenhofen, Germany) was
used as a molecular weight marker.
Restriction digestion and loading of the gel
The prepared plug discs were incubated in ApaI
restriction buffer (provided by the manufacturer) at
25 °C for 15 min. Then, the restriction buffer was
removed and replaced with 200 μL of fresh restriction
buffer containing 30 U of ApaI (Promega, Madison,
WI, USA). The reaction tubes were shaken gently and
the discs were incubated at 25 °C for 2 h. Prior to
casting the gel, the restriction mixture was removed
from each tube and replaced with 200 μL of 0.5× TBE
(10× TBE is 0.89 M Tris, 0.89 M boric acid, and 20
mM EDTA, pH 8.3). They were loaded into the
appropriate wells, which were made using a 15-slot
comb; each slot was 1.5 mm thick (Bio-Rad
Laboratories Inc, CA, USA).
Electrophoresis
Electrophoresis was performed in a contourclamped homogeneous electric field (CHEF) using a
CHEF Mapper apparatus (Bio-Rad Laboratories Inc,
CA, USA). The gels were covered with 2000 mL of
0.5× TBE. The running temperature was set at 14 °C.
Total run time was 19 h, with switch times ranging
from 5 to 20 s and linear ramping; run voltage was 6
V cm−1. The gels were stained for 30 min with 300 mL
of ethidium bromide solution (1 μg mL−1) and
destained for 45 min in distilled water with gentle
shaking. The gels were observed under UV
illumination and photographed using an imaging and
documentation system (Quantity One SW, Bio-Rad
Laboratories, CA, USA). Digital images were stored
electronically.
Data analysis
Data analysis of PFGE patterns was performed
visually, and the band patterns were interpreted
according to the criteria suggested by Tenover et al.
(14), with a difference of 6 bands or less used to define
epidemiological relatedness.
Definitions
A. baumannii acquisition
If an endotracheal aspirate culture was negative for
A. baumannii at patient admission and positive for A.
baumannii 48 h after admission, the patient was
defined as A. baumannii colonized.
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A. baumannii infection
The Centers for Disease Control and Prevention
(CDC) standard criteria were used to define infection
(15).
Multidrug resistance
Diminished susceptibility to 2 or more of the
following 5 antibiotic classes: antipseudomonal
cephalosporins, carbapenems, β-lactam-β-lactamase
inhibitor
combinations,
antipseudomonal
fluoroquinolones, and aminoglycosides (16).
Statistical analysis
Data are given as mean ± SD or median
(minimum-maximum). Univariate and multiple
logistic regression analyses (backward walled) were
performed for the significant risk factors of A.
baumannii acquisition and infection. All analyses
were carried out using the Statistical Package for the
Social Sciences (SPSS v.13.0).
Results

Turk J Med Sci

Table 1. Patient demographic characteristics (n = 98).
Characteristics
Age (mean ± SD)
APACHE II score (mean ± SD)
SOFA score (me an ± SD)
Underlying diseases and
interventions

54.83 ± 22.14
24.51 ± 7.64
7.78 ± 3.41

No. of patients (%)

Diabetes mellitus

20

(20)

Hypertension

30

(31)

Coronary heart disease

20

(20)

Chronic obstructive lung disease

20

(20)

Chronic renal failure

19

(19)

Cirrhosis

5

(5)

Cerebrovascular disease

22

(22)

Neoplastic disease

14

(14)

Trauma

11

(11)

Previous antibiotic use

91

(93)

Peripheral catheter

63

(64)

Central venous catheter

70

(71)

During the study period 408 patients were
admitted to the MICU. Of those, 129 patients stayed
in the MICU for less than 48 h, 118 patients were not
intubated, and 9 (2%) patients were considered
colonized at the time of admission. All of the
colonized patients were transferred from other wards
of the hospital.

Arterial catheter

13

(13)

Urinary catheter

92

(94)

Tracheostomy

31

(32)

Prosthesis

5

(5)

Operation

15

(15)

Open wound

13

(13)

Among 152 patients, endotracheal cultures were
taken from 98 (64.5%) patients during or at the end of
intubation and were evaluated for A. baumannii
colonization. Median age was 62.5 years (54.83 ±
22.14 years) with a range of 16-95 years. Fifty-seven
(58.2%) of the patients were male and 41 (41.8%) were
female. Median LOS in the MICU was 18.38 days
(range: 3-111 days) and median LOS in the hospital
was 27.55 days (range: 7-113 days). Fifty-six (57%) of
98 patients were transferred from other parts of the
hospital to the MICU. Demographic characteristics of
the patients are shown in Table 1.

Decubitus ulcer

14

(14)

Endotracheal cultures were taken from 86 patients
at the end of first week and 39 (45%) of these patients
were observed to be colonized with A. baumannii.
Respiratory secretions at the end of extubation were
obtained from 23 patients. Eleven of these patients
764

were extubated in the first week and only 1 (9%)
patient was colonized with A. baumannii, whereas 12
patients were extubated after the first week and 4
(33%) were colonized with A. baumannii. Overall, 44
(45%) of 98 patients were colonized with A.
baumannii. Mean time for A. baumannii acquisition
was 7.46 ± 3.74 days (range: 2-16 days).
During the study period A. baumannii infection
developed in 35 (80%) of 44 colonized patients. A.
baumannii infection developed in 8 (19%) patients,
unless colonization was determined. The majority of
A. baumannii infections were VAP (81%) and the
others were bacteremia (18.6%). Mean time for the
development of A. baumannii infection was 9.33 ±
5.84 days after admission (range: 4-33 days).
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Isolate resistance rates are shown in Table 2. All the
isolates were multi-drug resistant.
Table 2. Resistance rates of the A. baumannii isolates.
Antibiotics

Resistant isolates/n (%)

Ampicillin/sulbactam
Ceftazidime
Cefepime
Ciprofloxacin
Levofloxacin
Piperacillin/tazobactam
Tobramycin
Gentamycin
Amikacin
Imipenem
Meropenem

18/26
50/50
48/54
60/62
44/52
33/35
18/39
38/51
57/59
30/41
46/58

(69)
(100)
(89)
(97)
(85)
(94)
(46)
(75)
(97)
(73)
(79)

October 2009

Risk factors for A. baumannii colonization
According to univariate logistic regression
analysis, APACHE II score, age, length of intubation,
diabetes mellitus, coronary artery disease, and
prostheses were significant risk factors (Table 3).
However, according to multiple logistic regression
analysis only length of intubation (OR: 1.032, P =
0.014) and diabetes mellitus (OR: 4.140, P = 0.008)
were significant risk factors.
Risk factors for A. baumannii infection
According to univariate logistic regression
analysis, LOS in the MICU, LOS in the hospital,
tracheostomy, diabetes mellitus, and A. baumannii
colonization were significant risk factors (Table 4).

Table 3. Risk factors for A. baumannii colonization based on univariate logistic regression analysis.
Risk factors
Age
Sex
APACHE II
SOFA
Diabetes mellitus
Hypertension
Coronary artery disease
Chronic obstructive lung diseae
Chronic renal failure
Chronic heart failure
Cerebrovascular disease
Cirrhosis
Neoplastic disease
Trauma
LOS-MICU
LOS-hospital
Previous antibiotic use
Length of antibiotic therapy
Peripheral venous catheter
Central venous catheter
Arterial catheter
Urinary catheter
Nasogastric tube
TPN
Length of intubation
Tracheostomy
Prosthesis
Operation
Open wound
Decubitis ulcer

OR

95% CI

P

1.02
1.77
1.07
1.035
4.07
1.61
3.11
1.37
2.65
1.49
1.94
0.58
0.35
2.19
1.02
1.02
2.667
0.98
0.87
2.40
0.94
2.19
0.97
4.2
1.03
2.30
10.88
2.43
2.31
0.94

1.00-1.05
0.74-4.25
1.00-1.13
0.91-1.18
1.46-11.37
0.64-4.03
1.12-8.59
0.48-3.89
0.95-7.46
0.57-3.91
0.72-5.22
0.062-5.43
0.07-1.68
0.61-7.84
0.10-1.04
0.10-1.04
0.31-23.20
0.88-1.09
0.35-2.14
0.93-5.71
0.26-3.33
0.24-19.59
0.40-2.35
0.51-34.79
1.01-1.06
0.93-5.71
1.16-102.07
0.79-7.48
0.70-7.60
0.27-3.30

0.04
0.2
0.04
0.6
0.007
0.3
0.03
0.5
0.06
0.42
0.2
0.6
0.2
0.2
0.07
0.08
0.3
0.7
0.7
0.07
0.9
0.5
0.9
0.2
0.02
0.07
0.04
0.1
0.17
0.9
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Table 4. Risk factors for A. baumannii infection based on univariate logistic regression analysis.
Risk factors

OR

95% CI

P

Age
Sex
APACHE II
SOFA
Diabetes mellitus
Hypertension
Coronary artery disease
Chronic obstructive lung diseae
Chronic renal failure
Chronic heart failure
Cerebrovascular disease
Cirrhosis
Neoplastic disease
Trauma
LOS-MICU
LOS-hospital
Previous antibiotic use
Length of antibiotic therapy
Peripheral venous catheter
Central venous catheter
Arterial catheter
Urinary catheter
Nasogastric tube
TPN
Length of intubation
Tracheostomy
Prosthesis
Operation
Open wound
Decubitis ulcer
A. baumannii colonization

1.01
1.98
1.01
0.95
2.97
2.11
1.36
0.8
1.55
1.25
1.09
1.99
0.67
0.4
1.07
1.02
5.14
0.90
1.07
3.18
0.53
4.2
1.0
3.49
1.02
5.35
1.98
1.14
0.77
0.67
4.44

0.99-1.03
0.87-4.49
0.95-1.06
0.84-1.07
1.06-8.29
0.88-5.05
0.51-3.65
0.30-2.23
0.57-4.23
0.50-3.11
0.42-2.82
0.32-12.46
0.21-2.17
0.11-1.77
1.02-1.12
1.00-1.04
0.60-44.45
0.81-1.01
0.46-2.45
1.20-8.43
0.15-1.84
0.47-37.37
0.45-2.24
0.70-17.37
0.99-1.048
2.11-13.59
0.32-12.46
0.38-3.44
0.23-2.56
0.21-2.18
1.75-11.29

0.3
0.1
0.9
0.4
0.04
0.09
0.5
0.7
0.4
0.6
0.9
0.46
0.5
0.3
0.004
0.04
5.1
0.07
0.9
0.02
0.3
0.2
1.0
0.1
0.09
0.00
0.46
0.8
0.7
0.5
0.002

However, according to multiple logistic regression
analysis only A. baumannii colonization (OR: 3.962, P
= 0.006) and tracheostomy (OR: 4.857, P = 0.001)
were significant risk factors for infection.
Genetic relatedness
Genotyping analysis was performed for 59 isolates
(9 isolates from patients colonized at admission, 44
isolates from patients colonized in the MICU, and 6
isolates from infected patients in the MICU). Overall,
3 clones (clone A, B, and C) were indentified in the
patients; 88% belonged to clone A (52 isolates), 7% to
clone B (4 isolates), and 5% to clone C (3 isolates).
766

Fourteen clone A isolates (10 A-1 and 4 A-2) had
minor variations. Clones B and C were isolated from
patients colonized in the MICU.
Discussion
Staphylococcus aureus and nonfermentative gramnegative bacilli are reported to be the leading causes of
VAP (17). A. baumannii is one of the most frequent
nonfermentative gram-negative pathogens that cause
VAP in the series and causes alarm in ICUs due to
high drug resistance and to high mortality rates.
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Despite efforts directed at infection control, the
incidence of multidrug-resistant A. baumannii has
continued to rise. A. baumannii can survive on
surfaces for long periods of time and develops
resistance to many classes of antibiotics. Moreover, all
of the isolates in the present study were multidrug
resistant. In many infections and outbreaks of this
pathogen, medical devices and hospital staff hands are
the essential reservoirs of these isolates (14).
In our ICUs A. baumannii infections constitute the
most common cause of hospital-acquired infections
with a high rate of mortality (10,11). In a recent study
we evaluated A. baumannii bacteremia and 87.8% of
A. baumannii bloodstream infections occurred in
ICUs. The respiratory tract was the most common
source (39%) of bacteremia (11). Colonization of
respiratory secretions plays an important role in the
pathogenesis of pneumonia. Sedated patients on
mechanical ventilation usually aspirate the bacteria
around the cuff of the endotracheal tube, and due to
their underlying comorbid conditions they develop
pneumonia (16,18,19). Additionally, A. baumannii
adherence to human bronchial epithelial cells was
observed in vitro (20). Identification of specific risk
factors for airway colonization by specific
microorganisms will help focus infection control
measures.
On the other hand, endotracheal tubes predispose
to VAP by producing mucosal damage in the trachea,
and implanting exogenous and endogenous bacteria,
leading to accumulation of secretions by influencing
cough reflexes and the formation of biofilm (17).
Tracheostomy is another important risk factor for
infection. Tracheostomy tubes disrupt swallowing and
predispose to aspiration (21). Ibrahim et al. (22)
reported that the presence of a tracheostomy was
strongly associated with the development of
pneumonia. Moreover, tracheostomy was an
important risk factor for A. baumannii infection in
the present study.
A. baumannii usually grows in moist
environments. Respiratory devices (ventilators,
ventilator circuits, resuscitation bags, ventilator
spirometers, etc.) are the most common sources for
A. baumannii colonization and outbreaks. A.
baumannii can rapidly colonize intubated patients in
ICUs, in which it is endemic. Furthermore, patients’
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underlying diseases play a role in overcoming the
pulmonary defense mechanisms and lead to
colonization (23,24). In our ICUs 45% of intubated
patients were colonized with A. baumannii. The
length of intubation and diabetes mellitus were the
most important risk factors for colonization.
Colonization usually occurred during the first week
(88.6%) (mean colonization day was 7.3), as indicated
in the literature (25). In most studies prior use of
antibiotics was identified as an important risk factor
for acquisition of A. baumannii (26,27); however, it
was not an important risk factor in the present study.
The high proportion of antibiotic use in our ICUs
might explain this result and overuse of antibiotics
may explain the high rate of resistance observed in the
present study.
Environmental contamination from colonized
patients and its correlation with patient colonization
and infection have been reported. Environmental
cleanliness is a key factor in the control of outbreaks
(6-9,28,29); however, in the present study colonization
pressure was not determined, and hand and
environmental sampling was not carried out.
Colonized patients are the major reservoir for A.
baumannii, and patient-to-patient and environmentto-patient transmission usually occurs via HCWs’
hands. The genetic relatedness of the isolates (88% of
the isolates belonged to clone A) shows the
dissemination of the microorganism. The major
mode of transmission from patient to patient is the
contaminated hands of HCWs; therefore improving
hand hygiene compliance among HCWs and standard
precautions may be adequate to control multidrugresistant pathogens in endemic settings. In many
studies hand hygiene compliance is poor (< 50%) and
many factors influence compliance. In developing
countries understaffing, high workload, poorly
accessible sinks, and expensive alcohol-based hand
disinfectants are the major barriers for hand hygiene
compliance, and adequate compliance is practically
impossible (30). Nonetheless, in our ICUs alcoholbased products placed bedside, 3 washbasins for 9
beds, understaffing (the 24-h nurse-to-patient ratio is
0.7), and heavy workload are important reasons for
low compliance and healthcare-associated infections.
In a recent study Hugonnet et al. (31) reported that
26.7% of all infections acquired in the ICU could be
767
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prevented, providing that the 24-h nurse-to-patient
ratio is maintained at > 2.2. We also showed
dissemination of multidrug-resistant pathogens in our
other studies (11,32). After these studies and
surveillance reports by the infection control team that
showed high infection rates and cross-transmission,
a new MICU was built in the hospital. In this new
MICU, the bed-to-bed space is > 2.5 m, washbasins
are provided for every 2 beds, and 3 isolation rooms
were built. Nevertheless, the nurse-patient ratio
remains low, and we are implementing an infection
control program and surveillance of health-careassociated infections.
It has been suggested that colonization represents
the submerged part of an iceberg and that infection
reflects the tip of an iceberg. Colonization may be the
first step of an infection (33). Moreover, 80% of our
colonized patients manifested infection and infection
occurred in 8 patients, unless colonization was
determined; however, we screened only respiratory
secretions and only during the first week and
extubation. Colonization could have occurred at other
body sites and/or during the intervals between
screenings.

Turk J Med Sci

In conclusion, these results indicate the spread of
multidrug-resistant A. baumannii in intubated
patients. Colonized patients and environmental
contamination might act as the major reservoirs for
the bacteria and infection. Inadequate infrastructure
in ICUs (lack of staff, lack of isolation rooms, high
workload, etc.) in developing countries is the main
determinant of multidrug-resistant pathogen
dissemination. To control these pathogens,
determination of the ideal number of staff to reduce
workload, and contact isolation measures in
combination
with
vigorous
environmental
decontamination, hand hygiene, and appropriate
equipment decontamination is required.
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